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Abstract
Background: Hyaluronan (HA) is a glycosaminoglycan located in the interstitial space which is essential for both structural
and cell regulatory functions in connective tissue. We have previously shown that HA synthesis is up-regulated in a rat
model of experimental cardiac hypertrophy and that cardiac tissue utilizes two different HA synthases in the hypertrophic
process. Cardiomyocytes and fibroblasts are two major cell types in heart tissue. The fibroblasts are known to produce HA,
but it has been unclear if cardiomyocytes share the same feature, and whether or not the different HA synthases are
activated in the different cell types.
Methodology/Principal Findings: This study shows, for the first time that cardiomyocytes can produce HA. Cardiomyocytes
(HL-1) and fibroblasts (NIH 3T3) were cultivated in absence or presence of the growth factors FGF2, PDGF-BB and TGFB2. HA
concentration was quantified by ELISA, and the size of HA was estimated using dynamic light scattering. Cardiomyocytes
synthesized HA but only when stimulated by PDGF-BB, whereas fibroblasts synthesized HA without addition of growth
factors as well as when stimulated by any of the three growth factors. When fibroblasts were stimulated by the growth
factors, reverse dose dependence was observed, where the highest dose induced the least amount of HA. With the
exception of TGFB2, a trend of reverse dose dependence of HA size was also observed.
Conclusions/Significance: Co-cultivation of cardiomyocytes and fibroblasts (80%/20%) increased HA concentration far
more that can be explained by HA synthesis by the two cell types separately, revealing a crosstalk between cardiomyocytes
and fibroblasts that induces HA synthesis. We conclude that dynamic changes of the myocardium, such as in cardiac
hypertrophy, do not depend on the cardiomyocyte alone, but are achieved when both cardiomyocytes and fibroblasts are
present.
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Introduction
Hyaluronan (HA) is a prominent structural component in the
extracellular matrix (ECM), and is distributed ubiquitously in adult
vertebrate tissues. HA is a nonsulphated, linear, high molecular
weight glycosaminoglycan (GAG) composed of repeating disac-
charides, D-glucuronic acid and N-acetyl-D-glucosamine [1]. HA
has unique hydrodynamic properties, functioning as a biological
lubricant in joints during movement and providing resilience in
static conditions [2]. HA is synthesized by membrane-bound
synthases (HAS) at the inner surface of the plasma membrane. The
growing polymer is extruded through the membrane to the outside
of the cell as it is being synthesized. Three mammalian HAS’s
have been identified, HAS1, HAS2 and HAS3, which differ in
catalytic activity as well as in product size [3]. Several growth
factors regulate HA biosynthesis and the induction of the three
different HAS’s [4,5,6]. Different responses in HA biosynthesis are
depending on growth factor and cell type. In its native state, the
HA molecule (n-HA) can be composed of 2000–25,000 of
repeating disaccharides, with molecular weights ranging from
10
6 to 10
7 Da and with an extended length of 2–25 mm [3,7]. Via
receptors on the cell surface HA has also a signaling property.
These receptors include, for example, CD44 and RHAMM
(receptor for hyaluronan-mediated motility), [8,9,10]. HA-recep-
tor interactions mediate at least three physiological processes:
signal transduction, HA internalization and assembly of extracel-
lular matrices [11,12]. The length of the HA molecule affects its
signaling properties. For example, n-HA is anti-angiogenic while
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molecules interact differently with extracellular and cell-surface
HA-binding proteins[15]. Depending on its size, HA has been
shown to be involved in many processes including wound healing
and scarless fetal healing [16,17]. High concentrations of HA in
many embryonic tissues correlate with cell migration and
proliferation. In fact, similarities between developing tissues and
tumor tissues are demonstrated by higher concentrations of HA in
many malignant tumors than in corresponding benign tumors or
normal tissues [18,19,20]. The function of HA in the heart has so
far not been thoroughly investigated. However, absence of HA
causes abnormalities in heart and blood vessel development,
resulting in an embryonic lethal phenotype, showing the
importance of HA in heart formation [21,22]. HA synthesis has
also been shown to be up-regulated in experimental myocardial
infarction and myocarditis [23], as well as in an experimental rat
model of cardiac hypertrophy [24] where the increased amount of
HA was linked to different HA synthases in the hypertrophic
process. Fibroblasts are well known synthesizers of HA, while
cardiomyocytes have not been studied in this respect. It is still
unknown which cell types in the heart are involved in these
processes and if the two HASs in the hypertrophic process are
responsible for different sizes of HA, hence synthesized for
different purposes. To further investigate the role of HA in the
heart, cultured cardiomyocytes and fibroblasts were studied
separately. The aims of the study were the following: a) to
determine whether cardiomyocytes are capable of synthesizing
HA, using three different growth factors, well known to stimulate
HA synthesis in fibroblasts, fibroblast growth factor-2 (FGF2),
platelet-derived growth factor-BB (PDGF-BB) and transforming
growth factor-b2 (TGFB2) [4,5], b) to find out if there is a cell
signaling between fibroblasts and cardiomyocytes leading to HA
synthesis and in what manner the signal is transduced, and c) test
to determine if the size of the HA produced can be related to
biological effects.
Material and Methods
Cell culture
HL-1, a cell line derived from adult mouse heart, displaying
phenotypic features typical of adult cardiomyocytes [25], was
obtained from Dr. W.C. Claycomb (Louisiana State University
Medical Center, New Orleans). Cardiomyocytes plated in T-75
flasks coated with fibronectin (Sigma)-gelatin (Fisher Scientific)
were maintained in Claycomb Medium (JRH. Biosciences)
supplemented with 10% fetal bovine serum (JRH. Biosciences),
0.1 mM norepinephrine [consisting of 10 mM norepinephrine
(Sigma-Aldrich) dissolved in 30 mM ascorbic acid (Sigma)], 2 mM
L-glutamine (Life Technologies), and 100 U/mL penicillin,
100 mg/mL streptomycin (Life Technologies). During culture,
the medium was changed routinely every 24 h. Fibroblasts, NIH
3T3 cells [26] (ATCC CRL-1658, LGC Standards AB) were
cultured and passaged following the standard procedure in
Dulbecco’s modified Eagle’s medium (DMEM, Fisher Scientific)
containing 10% calf serum (JRH. Biosciences), 2 mM L-
glutamine, 100 U/mL penicillin, and 100 mg/mL streptomycin.
HL-1 and NIH3T3 cells were passaged twice per week by
trypsinization (Trypsin- EDTA, Life Technologies). All cultures
were kept in an atmosphere of 95% air-5% CO2,3 7 uC and at a
relative humidity of approximately 95%.
Pretreatments of cells
NIH 3T3 cells -alone and HL-1cells -alone were plated at a
concentration of 0.9610
6 cells/well into 6-well plates. In a
monolayer co-culture of HL-1 with NIH 3T3, 0.72610
6 HL-1
cells/well were mixed with 0.18610
6/well of NIH 3T3 cells to a 6-
well plate. After 72 h, cells were grown to confluence and all
media were replaced with serum-free and antibiotic-free media for
24 h. In the treatment groups, cells were then stimulated with
three different growth factors, known to induce HA synthesis in
cultured fibroblasts, dissolved in serum-free and antibiotic-free
media, FGF2 (5 ng/mL, 10 ng/mL), PDGF-BB (50 ng/mL,
100 ng/mL) and TGFB2 (5 ng/mL, 10 ng/mL) (Biosource,
Invitrogen), respectively, six replicates of each. Plates with no
growth factor addition were used as controls. After 24 h, the
media from each growth condition was collected and the cells were
then washed with ice-cold phosphate buffered saline (PBS)
(without Ca & Mg, Fisher Scientific), and subsequently harvested
by trypsination or scraping and placed in RNAlater (Qiagen).
Quantitative analysis of hyaluronan
The six replicates of media were diluted 20–100 times in PBS
and analyzed for HA content in duplicate by an enzyme-linked
binding protein assay (Corgenix) according to the manufacturer’s
instructions. Absorbance was read at 450 nm with correction at
650 nm on a spectrophotometer (Multiscan Ascent, Thermo
Labsystems). Data were expressed as mean6SD.
RNA preparation
For each cell group, total RNA was isolated from three wells
using the RNeasy Fibrous Tissue Kit (Qiagen). The concentration
of the RNA was measured in a NanoDrop ND-1000 Spectropho-
tometer (NanoDrop Technologies Inc.) and the integrity of the
RNA was analyzed in a 2100 Bioanalyser (Agilent Technologies
Inc.). Omniscript RT Kit (Qiagen) was used to synthesize cDNA.
Real-time polymerase chain reaction
Relative quantification of gene expression changes was
performed using an Applied Biosystems Prism 7900HT Sequence
Detection System according to the manufacturer’s specifications
(Applied Biosystems). Mouse cDNA-specific TaqMan Gene
Expression Assays for HAS1, HAS2 and HAS3 from Applied
Biosystems were used. The mouse D-glyceraldehyde-3-phosphate
dehydrogenase (Gapdh) gene was used as an endogenous control
(part number 4352338E; Applied Biosystems). All samples were
run in triplicate, and amplification was analyzed using Applied
Biosystems Prism Sequence Detection Software version 2.3.
Hyaluronan purification
Hyaluronan samples were purified from cell media of cultured
cardiomyocytes and fibroblasts. Four mL of cell media were
concentrated to 50 mL using 10 kDa cut-off Ultra Cell filter-unit
(Millipore) by 15 min centrifugation at 4,0006g using a centrifuge
(Sigma 4K10) equipped with a swing-out rotor. Concentrated
samples were diluted with 1 mL of 100 mM CaCl2 in 20 mM
TRIS-HCl buffer at pH 7.4. A total digestion of proteins, present
in the growth medium, was utilized using Pronase (Boehringer
Mannheim) at a concentration of 2 mg/mL in each sample. The
protein digestion was allowed to continue for 72 h at 40uC and
subsequently quenched by increasing the temperature to 100uC
for 3 minutes. Digested peptides and amino acids, as well as
CaCl2, were removed using a 10 kDa cut-off Ultra Cell filter-unit
by 3615 min centrifugation at 4,0006g. After each concentration
step the samples were diluted with 1 mL of 20 mM TRIS-HCl
adjusted to pH 7.4.
Desalted HA samples were loaded on a DEAE-FF anion-
exchange column with a bead volume of 1 mL (GE-Life Science)
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column was washed with 5 and 8 column volumes of 20 mM
TRIS-HCl pH 7.4 containing 0 M or 0.2 M NaCl, respectively.
HA was eluted from the column with 8 column volumes of 0.4 M
NaCl 20 mM TRIS-HCl pH 7.4.
The eluted fraction was collected and concentrated to
approximately 1.5 mL as described above. The volume of the
concentrated samples was further reduced to 30 mL using a
0.5 mL 10 kDa cut-off Ultra Cell filter-unit using a Microfuge 18
tabletop centrifuge (Beckman Coulter) at 14,000 rpm. The buffer
was changed by 3 steps of 15 min centrifugation followed by
dilution with 0.5 mL of 100 mM NaCl in D2O using the same
concentration device. In all concentration steps the filters were
washed with 0.1 M NaOH followed by careful rinsing with the
appropriate buffer to avoid contamination of glycerol in the
samples.
The purity of the samples was controlled by SDS-page, for
detection of residual proteins after Pronase digestion, and by
NMR to detect any other impurities, such as lipids and DNA.
Dynamic light scattering size analysis of hyaluronan
The size of HA synthesized by fibroblasts, cardiomyocytes or a
co-culture of the two cells types were estimated by DLS. The Z-
average value, which is the mean hydrodynamic diameter
weighted against the intensity of the DLS signal, was used to
estimate the mean hydrodynamic size of the different HA
molecules. Due to the hygroscopic properties of HA, the
hydrodynamic diameter of HA is highly dependent on the buffer
and salt conditions used in the DLS measurements. Therefore, the
hydrodynamic diameters of HA purified from cell media were
compared with those of HA with known molecular weights of
70 kDa, 450 kDa and 2420 kDa (Hyalose, L.L.C.) recorded at
identical conditions.
Each HA sample was intensively shaken at 4uC for 20 minutes,
to dissolve possible entanglements. To sediment remaining
entanglements, the samples were centrifuged for 20 minutes by a
Microfuge 18 tabletop centrifuge (Beckman Coulter) at
14,000 rpm, 50 mL of sample was added into a disposable low
volume cuvette with a 10 mm path length. DLS measurements
were conducted at 20uC using a Nano Zetasizer (Malvern
Instruments) equipped with a HeNe-laser with a wave length of
633 nm. Before each measurement the temperature was allowed
to equilibrate for 10 minutes. The back scattered light was
detected at an angle of 173 degrees. For each cell condition the
light scattering was measured for 200 seconds with 10 replicate
measurements. The DLS data was analyzed using the Dispersion
Technology Software v.5.10 (Malvern). Z-average, the mean
intensity weighted diameter, was collected for each HA sample.
Mean values and standard deviations from each measurement
were calculated and compared using GrapPad Prism v.5. Outliers
in Z-average were detected and rejected by calculation of the
Dixon’s Q ratio, using P=0.05 [27].
Crosstalk between cardiomyocytes and fibroblasts
After 24 h incubation, media from cardiomyocytes, fibroblasts
and co-cultured cardiomyocytes and fibroblasts were transferred to
both cardiomyocyte and fibroblast cultures. After additional 24 h
incubation, media were collected and the cells were harvested by
scraping and placed in RNAlater. Concentration of HA in media
from cardiomyocytes and fibroblasts were measured as described
above. To distinguish between extracellular signaling through
microvesicles and exocytosis of soluble molecules, media that
induced increased HA synthesis in cells was centrifuged to remove
cell debris, 3,0006g for 20 minutes at 4uC, repeated three times,
followed by 10,0006g for 20 minutes at 4uC, repeated three times.
The acquired supernatant was ultracentrifuged at 130,0006g
(49,000 rpm) for 2 h at 4uC in a MLS-50 rotor and a Beckman
Optima
TM MAX-E Ultracentrifuge (Beckman Coulter) to separate
pellet and media supernatant containing soluble molecules. Cells
were then incubated with pellet dissolved in new media or with
media supernatant. The concentration of HA in media was
measured and compared to controls incubated with unused media.
Gene expression in cells (n=3, except fibroblasts incubated with
media supernatant, where n=2) was analyzed with Illumina
Beadstation (Illumina, San Diego).
To investigate the presence of HA interaction with cardiomy-
ocytes, n-HA, 10 mg/mL, 800–1200 kDa (Select-HA
TM 1000) or
o-HA, 50 mg/mL, 6-mer (HYA-OLIGO6EF-1) (Hyalose, L.L.C.)
was added to cardiomyocytes in Claycomb media, followed by
24 h incubation. The cells were harvested by scraping and placed
in RNAlater.
Differential gene expression, analyzed with Illumina Beadsta-
tion, was used to detect intracellular signaling resulting in changed
transcription, compared to control cells (n=2 in each group).
Microarray gene expression
Aliquots of total RNA were converted to biotinylated double-
stranded cRNA according to the specifications of the Illumina
Totalprep RNA Amplification Kit (Ambion). The labelled cRNA
samples were hybridized to MouseRef-8 Expression Beadchip
(Illumina), incubated with streptavidin-Cy3 and scanned on the
Illumina Beadstation GX.
Data analysis of gene expression microarrays
To determine differentially expressed genes microarray data
were analyzed using gene expression module in Illumina
Beadstudio software, version 3.3.7. Intensity data was normalized
using the Beadstudio cubic spline algorithm. Significant differen-
tial expression was calculated using the Beadstudio software by
applying multiple testing corrections using Benjamini and
Hochberg False Discovery Rate (FDR) [28,29]. All data is
MIAME compliant and is available through NCBIs Gene
Expression Omnibus (GEO) (GEO Series accession number
GSE21675 and GSE21676).
The gene expression fold change of the stimulated cells was
calculated as the average signal value relative to the average signal
value for the control cells. A significant up-regulation was defined
as a foldchange $1.5 and a significant down-regulation was
defined as foldchange #0.67. Statistical significance was set at
P,0.05. To avoid selecting genes with high foldchange due to low
signal intensity a minimum signal intensity value was utilized. For
up-regulated genes the signal intensity was set at .50 in the
stimulated cell group. For down-regulated genes the signal
intensity was set at .50 in the control cell group.
Results
Quantitative analysis of hyaluronan in cell media
HA concentration in cultured cardiomyocytes and fibroblasts
was quantified to determine HA synthesis in response to
stimulation by the different growth factors FGF2, PDGF-BB and
TGFB2. The only growth factor that caused cardiomyocytes to
synthesize HA was PDGF-BB at 100 ng/mL in the media.
Fibroblasts on the other hand synthesize HA with or without any
addition of growth factors. The addition of growth factors showed
that FGF2 and PDGF-BB at higher concentrations (10 and
100 ng/mL) induced a lower concentration of HA than at lower
concentration (5 and 50 ng/mL). TGFB2 induced the highest
Hyaluronan and Cardiomyocytes
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concentration (Figure 1A).
Co-culturing cardiomyocytes and fibroblasts resulted in in-
creased HA concentration compared to cells cultured separately,
especially when taking into account the lower amount of
fibroblasts in the co-culture.
In contrast, FGF2 and PDGF-BB stimulated co-cultured cells
resulted in lower HA concentration in the media compared to cells
cultured alone. Media from co-cultured cells stimulated with
TGFB2 contained twice as much HA as in TGFB2 stimulated
fibroblasts (Figure 1A).
Real-time polymerase chain reaction analysis of
hyaluronan synthases
Concerning assessment of expression of Has genes, the
endogenous control Gapdh, used in real-time PCR analysis to
normalize for differences in the amount of total RNA added, were
in some cell/growth factor combinations not at a consistent level
between samples and controls. Therefore, the b-actin and 36B4
genes were also tested as endogenous controls but with the same
result. For this reason the real-time PCR results have only been
used as a detection of expression of the different Has’s without the
possibility to calculate foldchange and significance of changes in
expression (Table 1).
Dynamic light scattering size analysis of hyaluronan
The size of HA synthesized by fibroblasts, cardiomyocytes or
co-culture of the two cell types was estimated by dynamic light
scattering (DLS). The Z-average value of HA with known
molecular weights of 70 kDa, 450 kDa and 2420 kDa (Hyalose,
L.L.C.) gave Z-average values of 60620 nm, 90615 nm and
120615 nm, respectively (Figure 2).
Figure 1. HA concentration and size in cell media. Cultured cardiomyocytes, fibroblasts and co-cultured cells (80%/20%) was stimulated with
growth factors (FGF2, fibroblast growth factor-2, PDGF-BB, platelet-derived growth factor-BB and TGFB2, transforming growth factor-b2). ‘‘Low’’
indicates a growth factor concentration in the media of 50 ng/mL for PDGF-BB and 5 ng/mL for FGF2 and TGFB2. ‘‘High’’ indicates a growth factor
concentration in the media of 100 ng/mL for PDGF-BB and 10 ng/mL for FGF2 and TGFB2. HA concentration was measured with an enzyme-linked
binding protein assay. HA size was estimated with DLS.
doi:10.1371/journal.pone.0014393.g001
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when stimulated with a high concentration of PDGF-BB. Under
other conditions cardiomyocytes did not produce any detectable
levels of HA (Figure 1B).
Non-stimulated fibroblasts produced HA with a hydrodynamic
diameter of 175625 nm. Upon stimulation by low levels of FGF2,
fibroblasts released HA with a diameter of 140620 nm, whereas
fibroblasts cultured with high levels of FGF2 produced HA with a
diameter of 60615 nm. Fibroblasts stimulated by the low dose of
PDGF-BB produce HA with a diameter of 100615 nm. When the
fibroblasts were stimulated by a high dose of PDGF-BB the
concentration of HA became too low to ensure reliable DLS
measurements. The different concentrations of TGFB2 showed
little effect on the size of produced HA, with a hydrodynamic
diameter of 110615 nm and 11065 nm for the low and high
concentration of this growth factor, respectively (Figure 1B).
When cardiomyocytes and fibroblasts were co-cultured without
any growth factors they secreted HA with a diameter of
160620 nm. The addition of low levels of FGF2 induced HA of
115645 nm, whereas the high level of FGF2 yielded no detectable
HA. Low levels of PDGF-BB did not induce a HA concentration
high enough for reliable DLS measurements, whereas a high dose
of PDGF-BB yielded HA with a size of 220680 nm. When a low
dose of TGFB2 was added to co-cultured cells, HA with a size of
170635 nm was produced, whereas the high concentration of
TGFB2 resulted in HA with a diameter of 85615 nm (Figure 1B).
In four of the HA size measurements a larger standard deviation
of HA were observed. This was caused by a larger range of sizes of
the HA molecules produced under these specific conditions, and
not caused by impurities or HA aggregates.
In one of the fibroblast control samples one light scattering
measurements was identified as an outlier by Dixons Q test (P-
0.05) and excluded from the calculated mean value. The identified
outlier was most likely caused small amounts of HA aggregates.
Crosstalk between cardiomyocytes and fibroblasts
The presence of signaling crosstalk between cultured cardio-
myocytes and fibroblasts that induces HA synthesis was elucidated
by quantification of HA and gene expression analysis of both cell
types. Measurements of HA concentration in cell media and gene
expression analysis were used to elucidate the existence of
signaling crosstalk between cardiomyocytes and fibroblasts. Three
general ways of mediating signaling crosstalk between cells were
considered. Direct cell contact, extracellular signaling transferred
by microvesicles released into media [30] or extracellular signaling
transferred through exocytosis of soluble molecules into media.
Synthesis of HA by fibroblasts increased after incubation with
Claycomb media from either co-cultured cells or cardiomyocytes
alone, compared to both fibroblasts incubated in DMEM and
fibroblasts incubated in fresh, unused Claycomb media
(Figure 3,4). A lower HA concentration was obtained after
incubation of fibroblasts with fresh, unused Claycomb media.
Fibroblasts which were incubated with pellet from ultracentrifu-
gation of Claycomb media from cardiomyocytes, dissolved in
DMEM showed similar HA concentration to fibroblast controls
while fibroblasts incubated in the supernatant of ultracentrifuged
Claycomb media from cardiomyocytes demonstrated a two-fold
increase in HA concentration (Figure 4). Cardiomyocytes showed
no synthesis of HA irrespective of media added (Figure 3).
Gene expression analysis of fibroblasts incubated for 24 h with
Claycomb media transferred from cardiomyocytes, resulted in 333
differentially expressed genes compared to fibroblasts incubated
with unused Claycomb media (Table 2) (Table S1). The same
analysis of fibroblasts incubated for 24 h with ultracentrifuged
Claycomb media supernatant transferred from cardiomyocytes,
resulted in 96 differentially expressed genes (Table 2) (Table S2).
In both cases the Tgfb2 gene was up-regulated 3-fold. Data and
information is available through NCBI’s GEO (accession number
GSE21675).
Gene expression in cardiomyocytes treated with n-HA and o-
HA was analyzed to determine if HA mediate intracellular signals
leading to changes in gene transcription in cardiomyocytes. The
addition of n-HA and o-HA to Claycomb media before incubation
for 24 h, affected cardiomyocytes gene expression. When n-HA
was added to Claycomb media 35 differentially expressed genes
were detected, and 63 genes were detected with o-HA added
(Table 2) (Table S3, S4). Data and information is available
through GEO (accession number GSE21676).
Discussion
In this study HA synthesis was investigated in two major cell
types in heart tissue, cultured cardiomyocytes and fibroblasts to
better understand the function of HA in the heart.
While fibroblasts are recognized as the main source of HA in
connective tissues including in the heart, in this study the ability of
cardiomyocytes to synthesize HA is reported. Cardiomyocytes
cultured without growth factors or stimulated with FGF2 or
TGFB2 synthesized no detectable levels of HA. However, the
higher concentration of PDGF-BB (100 ng/ml) activated synthesis
of HA in cardiomyocytes. Thus, cardiomyocytes must express
HAS and indeed, confirmed by real-time PCR findings showing
both Has2 and Has3 transcription. The absence of HA synthesis at
the lower PDGF-BB concentration may indicate a threshold above
Table 1. HA synthases detected with real-time PCR.
Cell type/growth factor Has1 Has2 Has3
Cardiomyocytes/PDGF-BB n.d. d d
Fibroblasts/PDGF-BB n.d. d n.d.
Fibroblasts/FGF2 n.d. d n.d.
Fibroblasts/TGFB2 n.d. d d
Co-cultured cells/PDGF-BB n.d. d n.d.
Co-cultured cells/FGF2 n.d. d n.d.
Co-cultured cells/TGFB2 n.d. d n.d.
d., detected. n.d.; not detected.
doi:10.1371/journal.pone.0014393.t001
Figure 2. Size measurement of HA with known molecular
weigths. The hydrodynamic diameters of HA with known molecular
weights of 70 kDa, 450 kDa and 2420 kDa.
doi:10.1371/journal.pone.0014393.g002
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while fibroblasts are the primary source of HA in the myocardium,
cardiomyocytes could be a secondary producer of HA that initiate
their synthesis when PDGF-BB levels are high. The range in
hydrodynamic diameter of the HA synthesized coincided to some
extent the sizes of HA seen in fibroblasts and co-cultured cell
controls. Thus, cardiomyocytes might produce HA of similar size
to fibroblasts when an acute need for high amounts of HA arises to
support HA synthesis derived from fibroblasts.
Adding HA to cardiomyocyte cultures showed that both oligo
HA and native HA influence transcription of cardiomyocyte
genes. Hence, cardiomyocytes were shown here to both produce
and be affected by HA in their environment.
A pattern of decreased concentration and size of HA was
observed with increased concentration of FGF2 or PDGF-BB in
media from both fibroblasts and co-cultured cells (80% cardio-
myocytes and 20% fibroblasts). This may be explained by
hyaluronidase expression induced by FGF2 and PDGF-BB.
Induction of hyaluronidases by PDGF-BB has been shown in
human dermal fibroblasts [6]. The exception from this pattern was
co-cultured cells stimulated with PDGF-BB at the higher
concentration. Most likely, the cardiomyocytes contributed to
the observed higher HA concentration, stimulated by PDGF-BB at
the higher concentration. In co-cultures, containing only 20%
fibroblasts and without addition of growth factors, HA was
synthesized in equal amounts compared to fibroblast controls. It is
Figure 3. HA concentration in media transferred between different cell types. HA concentration in media was measured before and after
transfer between different cell types. After 24 h Claycomb media was transferred from Cm and co-cultured cells to Fb and DMEM media was
transferred from Fb to Cm and co-cultured cells. Cm, cardiomyocytes; Fb, fibroblasts.
doi:10.1371/journal.pone.0014393.g003
Figure 4. HA concentration in ultracentrifuged media. Claycomb media that induced increased HA synthesis in Fb was ultracentrifuged. Pellet
after ultracentrifugation was dissolved in DMEM. Fb was incubated for 24 h with pellet in DMEM and Claycomb media supernatant. Fb was also
incubated with fresh, unused Claycomb media. Fb, fibroblasts.
doi:10.1371/journal.pone.0014393.g004
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since cardiomyocytes alone did not synthesize HA at all, indicating
a synergistic effect between the cell types. Furthermore, sizes of
HA were larger in media from co-cultures than from cardiomy-
ocytes alone, indicating an additional control of the synthesis
derived from the interaction of the two different cell types.
In co-cultured cells, stimulated by FGF2 and PDGF-BB, this
synergistic effect may be masked by increased hyaluronidase
activity which could explain the low levels of HA seen in co-
cultured cells compared to stimulated fibroblasts alone.
The synergistic effect on HA synthesis seen in co-cultured cells
affecting seems to be caused by intercellular signaling between
cardiomyocytes and fibroblasts. When culturing fibroblasts with
media previously incubated with cardiomyocytes, an increase in
HA concentration was observed. However, fibroblasts incubated
with unused cardiomyocyte media did not increase their HA
synthesis. Ultracentrifugation of the HA synthesis inducing media
revealed that the HA inducing factor(s) was (were) to be found in
the supernatant, thus most likely a soluble molecule. Microarray
gene expression analysis of fibroblasts incubated with HA inducing
media revealed a number of differently expressed genes, of which
Tgfb2 was one. The Tgfb2 gene was 3-fold up-regulated both in
fibroblasts incubated with total media from cardiomyocytes as well
as cardiomyocyte media supernatant, showing a consistent effect
on the regulation of the Tgfb2 gene. Exogenously added TGFB2 to
fibroblast media revealed TGFB2 to be a potent inducer of
HA synthesis in the fibroblasts, where a 6 times higher HA
concentration compared to controls was observed. Tgfb2 has
previously been shown to be the highest up-regulated growth
factor gene in hypertrophic cardiac tissue, both in early and late
state of the hypertrophic process, where both expression of Has1
and Has2 as well as increased HA synthesis have been observed
[31]. In a recent publication it was shown in the developing heart
that TGFB2 modulates Has2 expression and HA production with
subsequent induction of epithelial to mesenchymal transformation
[32]. In the co-cultured cells with only 20% fibroblasts, TGFB2
induced a doubling of HA concentration compared to TGFB2
treated fibroblasts alone. This may be caused by a cumulative
effect of the observed intercellular signaling from cardiomyocytes
to fibroblasts, with subsequent up-regulation the Tgfb2 gene
together with the exogenously added TGFB2.
Cardiomyocyte controls expressed several genes coding for
growth factors which could be candidate genes for the unknown
factor secreted by cardiomyocytes, which might include connective
tissue growth factor (Ccn2/Ctgf), insulin-like growth factor 1 and 2
(Igf-1, 2) and Tgfb1. TGFB1 has been shown to up-regulate the
Tgfb2 gene in a pancreatic cancer cell line [33]. However, it has
also been reported that CCN2 acts as a cofactor to TGFB1, which
supports the possibility that the HA synthesis inducer can be a
combination of two factors [34].
The addition of growth factors in cell media consistently
affected the HA size, demonstrating that growth factors not only
influence the amount of synthesized HA also induced a change in
HA size. In most cases, the cells produced HA in smaller size when
stimulated with growth factors. The predominant synthase gene
expressed was Has2, suggesting that HA size was not controlled by
shift in HAS expression.
If the reduced size is caused by hyaluronidase activity, the short
o-HA fragment most likely also mediates intracellular signaling, as
demonstrated by the change in gene expression in cardiomyocytes
by adding o-HA.
Both Has1 and Has2 have been detected in myocardial tissue
from growing rat hearts [24]. In cultured cardiomyocytes and
fibroblasts, only Has2 (and not Has1) was detected both in controls
and all growth factor treated combinations. In PDGF-BB treated
cardiomyocytes and TGFB2 treated fibroblasts Has3 was also
expressed. One reason for Has1 not being expressed could be the
absence of vascular cells in the cell cultures. This is in concordance
with a work by Li et. al. where PDGF-BB induced Has expression
in human dermal fibroblasts showed a high expression of Has2
with Has1 and Has3 also expressed but at low levels [6].
The ability of cardiomyocytes to send out a request to
fibroblasts to synthesize HA reveals that cardiomyocytes need
HA. When fibroblasts respond with HA synthesis, the cardiomy-
ocytes detect the HA signal, and after signal transduction, a
changed gene transcription in the cardiomyocytes is achieved.
Table 2. Number of differentially expressed genes after each filtering step.
Filtering step Cm with oHA Cm with nHA Fb with Cm media Fb with Cm media sup.
Differential 554 493 1384 501
P-value,0.05 288q 266Q 69q 424Q 695q 689Q 201q 300Q
QQQQ
FDR 130 105 400 102
75q 55Q 4q 101Q 213q 187Q 21q 81Q
QQQQ
Detection 111 45 335 96
P-value,0.05 68q 43Q 3q 42Q 177q 158Q 21q 75Q
QQQQ
Foldchange 65 42 333 96
.1.5, ,21.5 27q 38Q 2q 40Q 175q 158Q 21q 75Q
QQQQ
Avg. sign. 63 35 333 96
.50 37q 26Q 2q 33Q 175q 158Q 21q 75Q
Multiple testing corrections using False Discovery Rate was applied. A significant up-regulation was defined as a foldchange .1.5 and a significant down-regulation was
defined as foldchange ,21.5. A minimum signal intensity value of 50 was utilized. Cm, cardiomyocytes; Fb, fibroblasts; sup. supernatant after ultracentrifugation, Avg.
sign., average signal; FDR, False Discovery Rate; q, up-regulated; Q, down-regulated.
doi:10.1371/journal.pone.0014393.t002
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carried out. However, when the different cell types are cultured
alone, the important crosstalk between cells is lost. If the
cardiomyocyte fails to detect HA in its proximity, it will not
undergo the following gene transcriptional changes. Thus, it is
evident that cardiomyocytes collaborate with fibroblasts to
optimize growth, where HA is a part of the cardiomyocyte
extracellular matrix.
The discovery that cardiomyocytes under certain circumstances
can synthesize HA themselves increases our recognition of further
possible regulatory activities of cardiomyocytes.
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